The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities in Alabama, Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin, and Wyoming. The Company was incorporated in 2019 and is headquartered in Eagle, Idaho.…
Pennant Group to Participate in the 2026 Stephens Annual Investment Conference
The Pennant Group (NASDAQ: PNTG) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 9,700 employees.
The shares were at 34.64 USD on 20 November 2026, up 45.9% over 52 weeks. Its 52-week range is 23.50 USD to 44.24 USD: the price is 21.7% below the high and 47.4% above the low.
At a market capitalisation of 1.22B USD, it trades at 34.3 times trailing earnings and 22.0 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.8, a premium of 44% for PNTG.
The Pennant Group reports return on equity of 8.9%, an operating margin of 6.1% and revenue up 32.0% year over year.
Its debt exceeds its cash by 470.54M USD, a debt-to-equity ratio of 1.36. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 6 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 48.50 USD is 40.0% above the current price. The next earnings report is expected on 24 February 2027.